ARCHIVES

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

This article is from The Cancer Letter archive.

Vol. 16 No. 48 | December 14, 1990

Download PDF Visit The Full Archive

Related Articles

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

NCI Rethinks Cancer Center Grants

March 14, 2014